RedHill Biopharma Ltd. (RDHL) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

RedHill Biopharma Ltd. (RDHL) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $2.1M, listed on NASDAQ, employing roughly 13 people, carrying a beta of 4.90 to the broader market. RedHill Biopharma Ltd. Led by Dror Ben-Asher, public since 2013-01-07.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for RDHL as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →